NCT06067048 2026-03-06
HOVON169CAD
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2 Active not recruiting
Clinical Trials
3 trialsNCT05952037 2026-01-02
A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia
BeOne Medicines
Phase 2 Active not recruiting
NCT04662255 2025-05-28
BRUIN-MCL-321
Eli Lilly and Company
Phase 3 Active not recruiting